Doctor Julius Nikorowitsch
University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
Effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation. The NOAH-AFNET 6 trial.
Event: EHRA 2024
Topic: Oral Anticoagulation
Session: Late-Breaking Science: devices
Feasibility and outcomes of ultrasound-guided transcutaneous access to the axillary vein for implantation, revision, and upgrade of cardiac electronic devices
Event: EHRA 2024
Topic: Device Complications and Lead Extraction
Session: Poster session on devices, others
3 Tesla magnetic resonance imaging in patients with cardiac electronic implantable devices: a single center experience
Event: ESC Congress 2022
Topic: Device Treatment
Session: Device treatment of arrhythmias
Applying the ESC 2016, the H2FPEF, and the HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the general population - a comparative approach
Event: ESC Congress 2021 - The Digital Experience
Topic: Diagnostic Methods
Session: Highlights from the Young in heart failure
Head-to-head comparison of the incremental value of the three established risk markers hs-troponin I, hs-C-reactive protein and NT-proBNP in secondary prevention of coronary artery disease
Event: ESC Congress 2020
Topic: Epidemiology, Prognosis, Outcome
Session: Coronary Artery Disease (Chronic) ePosters
Predictive value of soluble urokinase-type plasminogen activator receptor for cardiovascular death and non-fatal myocardial infarction in patients with coronary artery disease
Event: ESC Congress 2019
Topic: Epidemiology, Prognosis, Outcome
Session: Coronary Artery Disease – Epidemiology, Prognosis, Outcome
ESC 365 is supported by
